机译:在美国的活体供体肾移植受者中更好地从后代供体肾脏的贪污结果
Department of SurgeryJohns Hopkins University School of MedicineBaltimore Maryland;
Department of SurgeryJohns Hopkins University School of MedicineBaltimore Maryland;
Department of SurgeryJohns Hopkins University School of MedicineBaltimore Maryland;
Department of SurgeryJohns Hopkins University School of MedicineBaltimore Maryland;
Department of SurgeryJohns Hopkins University School of MedicineBaltimore Maryland;
Department of SurgeryJohns Hopkins University School of MedicineBaltimore Maryland;
Department of SurgeryJohns Hopkins University School of MedicineBaltimore Maryland;
Department of MedicineJohns Hopkins University School of MedicineBaltimore Maryland;
Department of SurgeryJohns Hopkins University School of MedicineBaltimore Maryland;
Department of SurgeryJohns Hopkins University School of MedicineBaltimore Maryland;
donors and donation: living; ethnicity/race; graft survival; health services and outcomes research; kidney transplantation/nephrology; kidney transplantation: living donor;
机译:在美国的活体供体肾移植受者中更好地从后代供体肾脏的贪污结果
机译:回复:后代活体肾脏受助人的劣质长期同种异体移植和患者结果编辑评论
机译:后代活体供体肾脏受体的较差的长期同种异体移植和患者结果
机译:DSA患者患者的肾脏移植的结果
机译:肾移植结果的回顾性分析:死者和活体供者肾脏移植患者中抗胸腺细胞球蛋白与Alemtuzumab的诱导免疫抑制作用。
机译:子代活体供肾的长期异体移植和患者预后不良
机译:在美国的活体供体肾移植受者中,从后代供体肾脏的更好的贪污结果